Review article · 2020
EditorialPublished 30 Aug 2021
Assessment of new tablet formulation of deferasirox to decrease persistent iron overload after long-term blood transfusions
Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, USA
Subjects
Pharmaceutical SciencesSimilar by topic
Conference abstract · 4 Jul 2019
Occurence, seasonal variation and long-term persistence of different SSRI concentrations in the lake systems of Southern Bangalore, Karnataka, India
Commentary · 31 Oct 2022
Medical Management to Decrease Long-Term Drug Resistance
Article · 3 Feb 2012
Formulation of oral iron chelator deferasirox in a new stable and suitable dosage form with optimum release parameters.
Conference abstract · 28 Aug 2017
Long-term stability of pharmaceutical formulations - prediction of recrystallization and amorphousamorphous phase separation
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Xiaoya Zhang”
